Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3527204
Max Phase: Preclinical
Molecular Formula: C14H15ClN6O2
Molecular Weight: 334.77
Molecule Type: Small molecule
Associated Items:
ID: ALA3527204
Max Phase: Preclinical
Molecular Formula: C14H15ClN6O2
Molecular Weight: 334.77
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1c(CO)cnc(Cn2cnc3c(Cl)nc(N)nc32)c1C
Standard InChI: InChI=1S/C14H15ClN6O2/c1-7-9(17-3-8(5-22)11(7)23-2)4-21-6-18-10-12(15)19-14(16)20-13(10)21/h3,6,22H,4-5H2,1-2H3,(H2,16,19,20)
Standard InChI Key: KPMYVWBVTQHIQI-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 334.77 | Molecular Weight (Monoisotopic): 334.0945 | AlogP: 1.31 | #Rotatable Bonds: 4 |
Polar Surface Area: 111.97 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 6.40 | CX LogP: 0.78 | CX LogD: 0.74 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.69 | Np Likeness Score: -0.67 |
1. Xu L, Woodward C, Khan S, Prakash C.. (2012) In vitro metabolism of BIIB021, an inhibitor of heat shock protein 90, in liver microsomes and hepatocytes of rats, dogs, and humans and recombinant human cytochrome P450 isoforms., 40 (4): [PMID:22217465] [10.1124/dmd.111.043000] |
Source(1):